Singapore-based medical testing firm Mirxes joins Jiangsu Hengrui Pharmaceuticals in revitalised market’s listing surge.

Jiangsu Hengrui Pharmaceuticals is planning to raise as much as US$1.27 billion via an initial public offering in Hong Kong, joining a wave of Chinese companies seeking to tap the city's market.

Pony AI Inc has confidentially filed for Hong Kong IPO to raise capital for expansion. Its stock surged and caught fire for ...

The world’s biggest IPO this year excludes U.S. onshore investors. The decision reduces geopolitical risks that loom over ...

Hong Kong is calling for robotaxi operator Pony AI . The $6 billion Chinese company is exploring an offering in the city just ...

(Reuters) -Chinese drug developer and producer Jiangsu Hengrui Pharmaceuticals is seeking to raise up to HK$9.89 billion ($1.27 billion) in a Hong Kong initial public offering, according to a ...

This digital payment services provider is likely to get a lift from China's initiatives to boost domestic consumption.

China’s Zijin Mining Group (OTCPK:ZIJMF) (OTCPK:ZIJMY) has picked Citic Securities Co. and Morgan Stanley (MS) to lead the ...

World’s largest maker of electric-vehicle batteries could expand its IPO deal to as much as US$5.3 billion if several upsize options are exercised.

SINGAPORE] Companies have been flocking to file applications for initial public offerings (IPOs) in Hong Kong amid ...

The Chinese battery giant is planning to raise as much as US$4.0 billion in the year’s biggest listing in Hong Kong.

Artificial intelligence-driven drug firm METiS Pharmaceuticals is considering an initial public offering in Hong Kong to ...